Exclusive

Publication

Byline

Location

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507)... Read More


Clinical Trial: Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750730) titled 'Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy ... Read More


Clinical Trial: SED Pack: Safety and Performance of a Medical Device Software for Predictive Monitoring During Sedation

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749781) titled 'SED Pack: Safety and Performance of a Medical Device Software for Predictive Monitoring Duri... Read More


Clinical Trial: Comparison of TLIP Block and QIP Block for Postoperative Analgesia After Lumbar Spine Surgery

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750418) titled 'Comparison of TLIP Block and QIP Block for Postoperative Analgesia After Lumbar Spine Surger... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherap... Read More


Clinical Trial: Comparison Between Low-Dose and High-Dose Nepafenac Sodium

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749027) titled 'Comparison Between Low-Dose and High-Dose Nepafenac Sodium' on July 31. Brief Summary: In S... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety... Read More


Clinical Trial: Acceptance and Commitment Therapy (ACT) Versus Cognitive Behavioural Therapy (CBT) for Fear of Cancer Recurrence (FCR) in Cancer Survivors and Their Spouses

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749560) titled 'Acceptance and Commitment Therapy (ACT) Versus Cognitive Behavioural Therapy (CBT) for Fear ... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Mo... Read More


Clinical Trial: Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748858) titled 'Improving Patient-Centered Care for Underserved Older African American Patients With Cardiov... Read More